8.2 Pharmacology of natural and synthetic cannabinoids
3 min read•august 9, 2024
Cannabinoids, both natural and synthetic, interact with our body's . Natural ones like THC and CBD come from cannabis plants, while synthetic versions are lab-made to mimic their effects. Understanding their pharmacology is key to grasping their impacts on the brain and body.
have varying effects and metabolize differently based on how they're consumed. Synthetic cannabinoids, often more potent and unpredictable, can be full or partial agonists. Their higher potency and complex interactions with our bodies can lead to more severe effects and health risks.
Natural Cannabinoids
Primary Cannabinoid Compounds
Top images from around the web for Primary Cannabinoid Compounds
Frontiers | Harmful Effects of Smoking Cannabis: A Cerebrovascular and Neurological Perspective View original
Is this image relevant?
Medihuana !!: Marihuana y sistema endocannabinoide View original
Is this image relevant?
Qué es el CBD, qué es el THC y cuál es la diferencia entre ambos - Contrainformación View original
Is this image relevant?
Frontiers | Harmful Effects of Smoking Cannabis: A Cerebrovascular and Neurological Perspective View original
Is this image relevant?
Medihuana !!: Marihuana y sistema endocannabinoide View original
Is this image relevant?
1 of 3
Top images from around the web for Primary Cannabinoid Compounds
Frontiers | Harmful Effects of Smoking Cannabis: A Cerebrovascular and Neurological Perspective View original
Is this image relevant?
Medihuana !!: Marihuana y sistema endocannabinoide View original
Is this image relevant?
Qué es el CBD, qué es el THC y cuál es la diferencia entre ambos - Contrainformación View original
Is this image relevant?
Frontiers | Harmful Effects of Smoking Cannabis: A Cerebrovascular and Neurological Perspective View original
Is this image relevant?
Medihuana !!: Marihuana y sistema endocannabinoide View original
Is this image relevant?
1 of 3
- Tetrahydrocannabinol (THC) acts as the main psychoactive component in cannabis
- Binds to cannabinoid receptors CB1 and CB2 in the brain
- Produces euphoria, relaxation, and altered perception
- Can cause side effects (anxiety, paranoia, impaired memory)
- functions as a non-psychoactive compound in cannabis
- Interacts with various receptors in the body, including serotonin receptors
- Exhibits potential therapeutic effects (anti-inflammatory, anxiolytic, anticonvulsant)
- Does not produce the "high" associated with THC
- Other cannabinoids found in cannabis include and
- CBN forms as THC breaks down and may have sedative properties
- CBG serves as a precursor molecule for other cannabinoids and shows potential medicinal benefits
Pharmacokinetics and Metabolism
- Pharmacokinetics of cannabinoids varies based on route of administration
- Inhalation results in rapid onset of effects within minutes
- Oral ingestion leads to slower onset (30-90 minutes) but longer duration
- Topical application produces localized effects with minimal systemic absorption
- differs significantly between consumption methods
- Inhalation yields highest bioavailability (10-35%)
- Oral ingestion results in lower bioavailability (5-20%) due to
- Sublingual administration improves bioavailability compared to oral ingestion
- Metabolism of cannabinoids primarily occurs in the liver
- Cytochrome P450 enzymes (CYP2C9, CYP3A4) play a key role in metabolizing THC
- THC metabolizes into , which is also psychoactive
- CBD metabolizes into various compounds, including
- Elimination of cannabinoids and their metabolites occurs through urine and feces
- Can be detected in urine for days to weeks after use, depending on frequency and amount consumed
Synthetic Cannabinoids
Types and Mechanisms of Action
- Synthetic cannabinoids encompass a diverse group of lab-created compounds
- Designed to mimic the effects of natural cannabinoids like THC
- Often more potent and unpredictable than natural cannabinoids
- Include substances like , , and
- Agonists bind to and activate cannabinoid receptors
- Full agonists produce maximum receptor activation (JWH-018)
- Partial agonists produce submaximal activation even at high doses (THC)
- Can lead to more intense and potentially harmful effects compared to natural cannabinoids
- Antagonists block the effects of cannabinoids at receptor sites
- Compete with agonists for binding to cannabinoid receptors
- Can be used to study cannabinoid receptor function and potential therapeutic applications
- Include compounds like , which was briefly used as an anti-obesity drug
Pharmacodynamics and Effects
- Pharmacodynamics of synthetic cannabinoids involve complex interactions with the endocannabinoid system
- Primarily target , similar to natural cannabinoids
- May also interact with other neurotransmitter systems (serotonin, dopamine)
- Can produce more severe and unpredictable effects than natural cannabinoids
- Synthetic cannabinoids often exhibit higher binding affinity for CB1 receptors compared to THC
- Results in more potent psychoactive effects
- Increases risk of adverse reactions (severe anxiety, psychosis, seizures)
- Chronic use of synthetic cannabinoids can lead to tolerance and dependence
- Downregulation of cannabinoid receptors may occur with prolonged exposure
- Withdrawal symptoms can be more severe than those associated with natural cannabis
- Synthetic cannabinoids pose significant health risks due to their potency and unpredictability
- Lack of quality control in production leads to inconsistent potency and composition
- Limited research on long-term effects and potential interactions with other substances
- Challenging for medical professionals to treat overdoses due to the variety of compounds
Key Terms to Review (28)
11-hydroxy-thc: 11-hydroxy-tetrahydrocannabinol (11-OH-THC) is a metabolite of delta-9-tetrahydrocannabinol (THC), the primary psychoactive compound found in cannabis. This compound is significant because it is formed in the liver after THC is ingested, and it is known to be more potent than THC itself, contributing to the overall effects of cannabis consumption. Understanding 11-OH-THC is crucial in exploring how cannabinoids interact with the body and their pharmacological profiles.
7-hydroxy-cbd: 7-hydroxy-cbd is a cannabinoid that is a derivative of cannabidiol (CBD), characterized by the addition of a hydroxyl group at the 7th carbon position. This modification can affect its pharmacological properties, potentially enhancing its therapeutic effects compared to standard CBD. Understanding how 7-hydroxy-cbd interacts with cannabinoid receptors and its impact on the endocannabinoid system is crucial in exploring the pharmacology of both natural and synthetic cannabinoids.
Am-2201: am-2201 is a synthetic cannabinoid that mimics the effects of natural cannabinoids like THC found in cannabis. It was first synthesized in 2009 and has become known for its high potency and unpredictability in effects, making it a subject of concern in drug safety and policy discussions.
Anti-anxiety treatment: Anti-anxiety treatment refers to various therapeutic approaches and medications designed to alleviate symptoms of anxiety disorders. These treatments can include pharmacological interventions, such as benzodiazepines and natural or synthetic cannabinoids, which act on specific neurotransmitter systems in the brain to produce calming effects. The effectiveness of anti-anxiety treatments varies among individuals, and understanding their pharmacology is crucial for optimizing patient care.
Bioavailability: Bioavailability refers to the proportion of a drug or substance that enters the systemic circulation when introduced into the body, and is available for therapeutic effect. It is crucial for understanding how different routes of administration can impact drug efficacy and safety, as it can vary widely between substances and their formulations, influencing how they interact with biological systems.
Cannabidiol (CBD): Cannabidiol (CBD) is a non-psychoactive compound found in cannabis plants, known for its potential therapeutic properties. Unlike THC, another prominent cannabinoid, CBD does not produce a 'high,' making it a focus for research in medical applications. Its interactions with the endocannabinoid system suggest that it plays a role in regulating various physiological processes, including mood, pain sensation, and inflammation.
Cannabigerol (cbg): Cannabigerol (CBG) is a non-psychoactive cannabinoid found in the cannabis plant, known as the 'mother of all cannabinoids' because it serves as a precursor to other major cannabinoids like THC and CBD. CBG has gained attention for its potential therapeutic properties, including anti-inflammatory, analgesic, and neuroprotective effects, which are being studied in the context of medical applications.
Cannabinol (CBN): Cannabinol (CBN) is a cannabinoid found in cannabis plants, primarily known for its potential sedative effects and its role as a degradation product of tetrahydrocannabinol (THC). As cannabis ages or undergoes exposure to heat and light, THC can convert into CBN, which has sparked interest in its pharmacological properties, particularly in the context of sleep and anxiety management.
CB1 and CB2 Receptors: CB1 and CB2 receptors are two primary types of cannabinoid receptors found in the body that play crucial roles in the pharmacological effects of both natural and synthetic cannabinoids. CB1 receptors are mainly located in the central nervous system and are responsible for the psychoactive effects of cannabinoids, while CB2 receptors are primarily found in the peripheral nervous system and immune tissues, influencing pain and inflammation responses. Understanding these receptors is key to comprehending how cannabinoids interact with the body and their therapeutic potential.
Cognitive impairment: Cognitive impairment refers to a decline in cognitive function, which can affect memory, attention, and the ability to think clearly. This condition can be influenced by various factors including substance use, neurological disorders, and mental health conditions, making it a significant concern in understanding how drugs interact with the brain and impact behavior.
Cp-47,497: cp-47,497 is a synthetic cannabinoid developed in the 1990s as part of research into cannabinoids for potential therapeutic uses. This compound acts primarily on the cannabinoid receptors in the brain, mimicking the effects of natural cannabinoids found in cannabis, but with significantly more potency and a different pharmacological profile. Understanding cp-47,497 is important in discussions about synthetic cannabinoids due to its influence on receptor activity and its potential implications for drug development and safety.
Cultural use of cannabis: Cultural use of cannabis refers to the traditional and social practices involving cannabis within various societies, where it is used for rituals, ceremonies, recreation, and medicinal purposes. This use is deeply embedded in cultural identities and can influence social norms, beliefs, and even legal frameworks surrounding the substance.
Delta-9-tetrahydrocannabinol (THC): Delta-9-tetrahydrocannabinol, commonly known as THC, is the main psychoactive compound found in cannabis. It interacts with cannabinoid receptors in the brain and body, producing effects such as euphoria, relaxation, and altered perception. THC is significant in understanding both natural and synthetic cannabinoids, as it serves as a model for studying their pharmacological effects and therapeutic potential.
Endocannabinoid system: The endocannabinoid system is a complex cell-signaling system in the body that plays a crucial role in regulating various physiological processes, including mood, memory, appetite, and pain sensation. It consists of endocannabinoids, receptors, and enzymes that work together to maintain homeostasis and respond to external stimuli, such as natural and synthetic cannabinoids.
Euphoric effects: Euphoric effects refer to intense feelings of happiness and well-being that can be induced by certain substances, including natural and synthetic cannabinoids. These effects are typically characterized by an elevated mood, a sense of relaxation, and enhanced sensory perception. The ability of cannabinoids to produce these euphoric effects is linked to their interaction with the endocannabinoid system in the brain, which plays a crucial role in regulating mood and emotion.
First-pass metabolism: First-pass metabolism refers to the process by which a drug's concentration is significantly reduced before it reaches systemic circulation. This phenomenon occurs primarily in the liver, where enzymes metabolize the drug after it is absorbed from the gastrointestinal tract but before it enters the bloodstream. Understanding first-pass metabolism is crucial because it affects the bioavailability of drugs, particularly those taken orally, and can influence the pharmacological effects of substances like cannabinoids.
Jwh-018: jwh-018 is a synthetic cannabinoid that was developed as a research chemical and is structurally similar to THC, the active compound in cannabis. It binds to the same cannabinoid receptors in the brain, primarily CB1 receptors, leading to effects that mimic those of marijuana. Its emergence as a designer drug has raised concerns regarding its safety and legal status.
Legalization trends: Legalization trends refer to the evolving legal frameworks and public attitudes towards the use of substances, particularly cannabis, reflecting a shift from prohibition to acceptance and regulation. This phenomenon is influenced by various factors including medical research, social movements, and changing perceptions of drug use. Legalization trends are crucial for understanding the pharmacology of natural and synthetic cannabinoids, as these shifts can impact research, availability, and public health policies surrounding cannabinoid use.
Michele Ross: Michele Ross is a notable researcher and advocate in the field of cannabinoid medicine, particularly focusing on the therapeutic uses of cannabis. She has contributed significantly to understanding how cannabinoids can affect the brain and mind, promoting research on both natural and synthetic cannabinoids for various medical conditions.
Natural cannabinoids: Natural cannabinoids are compounds that occur naturally in the cannabis plant, responsible for its psychoactive and medicinal effects. These compounds interact with the endocannabinoid system in the human body, influencing a variety of physiological processes including mood, memory, pain sensation, and appetite. Understanding natural cannabinoids is crucial for exploring both their therapeutic potential and the pharmacological effects they exert.
Neuroprotective effects: Neuroprotective effects refer to the mechanisms and actions that protect neuronal cells from injury, degeneration, or death. These effects are crucial in preventing or delaying neurodegenerative diseases and can be influenced by various substances, including natural and synthetic cannabinoids. Understanding how these protective actions work can lead to potential therapeutic strategies for conditions like Alzheimer's, Parkinson's, and multiple sclerosis.
Pain management: Pain management refers to the process of providing medical care that alleviates or reduces pain, enhancing the quality of life for individuals experiencing acute or chronic pain. It involves a combination of pharmacological and non-pharmacological interventions, including the use of opioids and cannabinoids to modulate pain perception and improve overall well-being.
Potential for addiction: Potential for addiction refers to the likelihood that a substance or behavior can lead to the development of dependency or compulsive use patterns in individuals. This concept is crucial when discussing various substances, as certain drugs, including both natural and synthetic cannabinoids, can trigger neurological pathways associated with reward and pleasure, which may foster addictive behaviors over time.
Raphael Mechoulam: Raphael Mechoulam is an Israeli organic chemist known for his pioneering research on cannabinoids, particularly the isolation and characterization of tetrahydrocannabinol (THC) and cannabidiol (CBD) from the cannabis plant. His work has laid the foundation for understanding the pharmacology of both natural and synthetic cannabinoids, making significant contributions to the field of medicinal cannabis and its therapeutic potential.
Regulatory history of marijuana: The regulatory history of marijuana refers to the evolution of laws and policies surrounding the cultivation, distribution, and use of marijuana, both for medicinal and recreational purposes. This history includes significant milestones such as prohibition, legalization movements, and the varying state and federal responses that shape how marijuana is treated legally today. Understanding this history is crucial to grasping how marijuana interacts with pharmacology and the development of both natural and synthetic cannabinoids.
Rimonabant: Rimonabant is a selective cannabinoid receptor antagonist that primarily targets the CB1 receptors in the brain. Initially developed for weight management and obesity treatment, it works by blocking the effects of endocannabinoids, which are naturally occurring compounds that can stimulate appetite and affect mood. This connection to cannabinoid pharmacology highlights its role in understanding how manipulating the endocannabinoid system can influence behaviors and physiological responses.
Schedule I substances: Schedule I substances are drugs that are classified by the federal government as having a high potential for abuse, no accepted medical use in treatment in the United States, and a lack of accepted safety for use under medical supervision. This classification reflects strict regulations and significant legal restrictions, influencing both the risks associated with these substances and their cultural significance, especially regarding their use as hallucinogens and cannabinoids.
Synthetic Cannabinoids like K2/Spice: Synthetic cannabinoids like K2 and Spice are man-made chemicals that mimic the effects of natural cannabinoids found in cannabis. These substances are often sprayed onto plant material and marketed as 'legal highs' or herbal incense, but they can cause unpredictable and potentially dangerous effects on users due to their high potency and varying compositions.